BPH-1358 is primarily used in the field of medicinal chemistry and drug development. It has shown potential as a therapeutic agent in the treatment of certain types of cancers, particularly those involving abnormal cell proliferation. The compound is being studied for its ability to inhibit specific enzymes or pathways that are crucial for the survival and growth of cancer cells. Additionally, BPH-1358 is being explored for its role in combination therapies, where it may enhance the efficacy of other anticancer drugs. Research is ongoing to determine its pharmacokinetics, safety profile, and optimal dosing regimens for clinical use.